Delivery Order SPE2DH25D0001-SPE2D425F410E
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract on August 12, 2025, by the Medical Supply Chain, a defense-focused federal agency, for CG8+ Cartridge products. The contract carries a ceiling value of $2,743.75 and is structured as a fixed-price delivery order with economic price adjustment provisions. The performance location is identified as North Chicago, Illinois, which aligns with Abbott's corporate headquarters and reflects the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,719.63 by the Medical Supply Chain, a defense-focused federal agency, on August 18, 2025. This fixed-price contract with economic price adjustment calls for cartridge chemistry 8-25 test analysis supplies, with performance to be completed at Abbott's facility in North Chicago, Illinois, by September 2, 2025. The contract was awarded on a full and open competition basis with no set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,130.88 on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. This fixed-price delivery order with economic price adjustment features a completion date of September 3, 2025, and will be performed at Abbott's facility in North Chicago, Illinois. The contract pertains to cartridge analysis and testing components, consistent with Abbott's core business...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,083.50 by the Medical Supply Chain, a Defense agency component, on June 16, 2025, with an ultimate completion date of June 18, 2025. The contract, issued under a fixed-price structure with economic price adjustment provisions, covers CG8+ cartridge supplies with performance in North Chicago, Illinois. This award was made through full and open competition with no set-aside designation...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $2,173.14 by the Medical Supply Chain agency (a Defense component) on September 10, 2025, with a completion date of September 12, 2025. The contract covers CG8+ cartridges and is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. This award represents a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Department of Defense's Medical Supply Chain on September 5, 2025, with completion expected by September 9, 2025. The contract, designated as 4569345436 and classified as a fixed-price delivery order with economic price adjustment provisions, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed at Abbott's facility in...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,394.94 under a fixed-price contract with economic price adjustment on June 12, 2025. This delivery order, issued by the Defense Medical Supply Chain, will be performed in North Chicago, Illinois, and represents a task order under a larger Blanket Purchase Agreement vehicle. The award was made through full and open competition with no set-aside designation. Based on Abbott's extensive...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,097.50 by the Defense-affiliated Medical Supply Chain agency on July 11, 2025, with an ultimate completion date of July 15, 2025. The contract, identified as CG8+ CARTRIDGE, was awarded without set-aside designation through full and open competition on a fixed-price basis with economic price adjustment provisions. Performance will be executed at Abbott's North Chicago, Illinois...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F410EDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,332.50 on July 15, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of EG7+ cartridge medical products to the place of performance in North Chicago, Illinois, with an ultimate completion date of July 17, 2025. This award represents a child contract utilizing a broader procurement vehicle and was awarded through full and open competition with no set-aside designation, reflecting the government's competitive procurement practices for critical medical supply chain support. Abbott Laboratories Inc. brings substantial expertise in point-of-care diagnostics and medical testing technologies to this engagement, drawing on its extensive track record of federal healthcare procurement across the Department of Veterans Affairs and other defense agencies. The company's established presence in federal medical device and diagnostic supply markets, including previous blanket purchase agreements and delivery orders for immunoassay analyzers and diagnostic equipment, positions it to efficiently fulfill this requirement. The expedited completion timeline—delivery within two days of award—indicates this represents an urgent replenishment of critical medical supplies to support active defense medical operations or federal healthcare delivery systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/15/25 |